A detailed history of Parkside Financial Bank & Trust transactions in Amgen Inc stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 3,769 shares of AMGN stock, worth $1.04 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
3,769
Previous 3,444 9.44%
Holding current value
$1.04 Million
Previous $1.08 Million 12.83%
% of portfolio
0.17%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$309.38 - $337.38 $100,548 - $109,648
325 Added 9.44%
3,769 $1.21 Million
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $39,938 - $48,535
-152 Reduced 4.23%
3,444 $1.08 Million
Q1 2024

May 01, 2024

BUY
$268.87 - $324.56 $7,797 - $9,412
29 Added 0.81%
3,596 $1.02 Million
Q4 2023

Feb 01, 2024

BUY
$255.7 - $288.46 $122,736 - $138,460
480 Added 15.55%
3,567 $1.03 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $28,205 - $35,018
-129 Reduced 4.01%
3,087 $829,000
Q2 2023

Aug 15, 2023

BUY
$214.27 - $253.37 $25,712 - $30,404
120 Added 3.88%
3,216 $714,000
Q1 2023

May 04, 2023

BUY
$225.79 - $275.2 $66,382 - $80,908
294 Added 10.49%
3,096 $748,000
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $27,483 - $34,921
120 Added 4.47%
2,802 $735,000
Q3 2022

Nov 01, 2022

SELL
$224.46 - $253.15 $4,713 - $5,316
-21 Reduced 0.78%
2,682 $604,000
Q2 2022

Jul 13, 2022

SELL
$230.71 - $256.74 $3,229 - $3,594
-14 Reduced 0.52%
2,703 $657,000
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $71,482 - $79,077
-326 Reduced 10.71%
2,717 $657,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $180,384 - $206,433
907 Added 42.46%
3,043 $684,000
Q3 2021

Oct 29, 2021

BUY
$212.27 - $248.7 $16,132 - $18,901
76 Added 3.69%
2,136 $455,000
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $42,277 - $46,904
-181 Reduced 8.08%
2,060 $502,000
Q1 2021

May 10, 2021

SELL
$221.91 - $258.6 $27,294 - $31,807
-123 Reduced 5.2%
2,241 $558,000
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $20,123 - $23,963
93 Added 4.1%
2,364 $544,000
Q3 2020

Nov 06, 2020

BUY
$234.65 - $260.95 $234 - $260
1 Added 0.04%
2,271 $577,000
Q2 2020

Aug 10, 2020

BUY
$197.81 - $242.74 $50,837 - $62,384
257 Added 12.77%
2,270 $536,000
Q1 2020

May 05, 2020

BUY
$182.24 - $241.7 $25,695 - $34,079
141 Added 7.53%
2,013 $408,000
Q4 2019

Jan 30, 2020

SELL
$189.21 - $243.2 $2,081 - $2,675
-11 Reduced 0.58%
1,872 $451,000
Q3 2019

Nov 05, 2019

BUY
$174.11 - $208.62 $8,183 - $9,805
47 Added 2.56%
1,883 $364,000
Q2 2019

Aug 06, 2019

SELL
$166.7 - $195.41 $11,002 - $12,897
-66 Reduced 3.47%
1,836 $338,000
Q1 2019

May 01, 2019

SELL
$180.87 - $203.88 $30,928 - $34,863
-171 Reduced 8.25%
1,902 $361,000
Q4 2018

Jan 31, 2019

BUY
$178.4 - $208.25 $41,388 - $48,314
232 Added 12.6%
2,073 $403,000
Q3 2018

Oct 12, 2018

BUY
$185.29 - $208.89 $35,760 - $40,315
193 Added 11.71%
1,841 $382,000
Q2 2018

Aug 03, 2018

SELL
$166.05 - $186.51 $498 - $559
-3 Reduced 0.18%
1,648 $305,000
Q1 2018

May 02, 2018

SELL
$169.43 - $198.0 $37,782 - $44,154
-223 Reduced 11.9%
1,651 $281,000
Q4 2017

Feb 05, 2018

BUY
$168.79 - $188.59 $41,691 - $46,581
247 Added 15.18%
1,874 $326,000
Q3 2017

Oct 27, 2017

BUY
$167.29 - $191.0 $272,180 - $310,757
1,627
1,627 $303,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $147B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.